Neal Evan Rothschild MD
Assistant Clinical Professor of Medicine, University Fla College of Medicine
Join to View Full Profile
1309 N Flagler DrWest Palm Beach, FL 33401
Phone+1 561-366-4100
Fax+1 561-366-4189
Dr. Rothschild is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStart Georgetown University HospitalFellowship, Medical Oncology, 1985 - 1987
MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 1984 - 1985- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1981 - 1984
Rutgers New Jersey Medical SchoolClass of 1981
Certifications & Licensure
FL State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
- Gulfstream FL-Palm Beach Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
- Join now to see all
Clinical Trials
- Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2007 Apr 01
- A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11
Publications & Presentations
PubMed
- 2 citationsBilateral Poorly Differentiated Adenocarcinoma of the Lacrimal Gland With Tumor Regression After Treatment With Pembrolizumab.Ann Q. Tran, Catherine J. Choi, Zakeya Mohammed Al-Sadah, Xiao Yi Zhou, Sander R. Dubovy
Ophthalmic Plastic and Reconstructive Surgery. 2020-04-09 - 43 citationsA phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.Patrick A. Ott, Anna C. Pavlick, Douglas B. Johnson, Lowell L. Hart, Jeffrey R. Infante
Cancer. 2019-04-01
Press Mentions
Is There a Distinct Standard of Care for “Integrative” Physicians?: The Woliner CaseOctober 13th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
